BRIOTECH, INC.

BRIOTECH HOCl is a globally-focused disruptive supplier of pure HOCl and deployable remotely controlled factories for community empowerment. We produce a pure HOCl from saltwater re-synthesis that has been shown to be a virtual bio mimic of the body’s own defense system (phagocytosis in white blood cells). HOCl stops replication of virtually all pathogens without creation of resistance & persistence mechanisms (superbugs). BrioHOCl solution was tested by NIH on the world’s worst pathogens (all prion species) resulting in unprecedented results for inactivation efficacy while maintaining lasting shelf stability and consistent safety profiles.

BRIOTECH has never wavered from its focus on what HOCl products can do for the good of mankind, in all aspects of health and wellness, and the company’s intent is to ensure a lasting, beneficial impact on as many people as possible throughout the world by delivering improvements to their daily lives from use of superior, pure, stable, safe and right-priced HOCl products. Applications and compendiums of scientific supporting data will be available in our comprehensive HOCl Codex, “The Handbook of HOCl” summer 2021.

BRIOTECH’s unique credentials, strategic management and technical team have raised the company’s status to become an industry leader in the world of HOCl. More information is available at brioglobal.com
As a profit-for-purpose company, 5% of its gross sales are dedicated to underserved populations, with a focus on “at risk women, children and indigenous people” through our foundation, BrioEarth